SCHOTT Pharma KGaA Future Growth
Future criteria checks 3/6
SCHOTT Pharma KGaA is forecast to grow earnings and revenue by 15.8% and 10.7% per annum respectively. EPS is expected to grow by 15.6% per annum. Return on equity is forecast to be 18.9% in 3 years.
Key information
15.8%
Earnings growth rate
15.6%
EPS growth rate
| Life Sciences earnings growth | 26.2% |
| Revenue growth rate | 10.7% |
| Future return on equity | 18.9% |
| Analyst coverage | Good |
| Last updated | 26 Nov 2024 |
Recent future growth updates
No updates
Recent updates
Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 9/30/2027 | 1,344 | 242 | 136 | 296 | 3 |
| 9/30/2026 | 1,192 | 209 | 93 | 252 | 9 |
| 9/30/2025 | 1,051 | 161 | 41 | 226 | 10 |
| 9/30/2024 | 967 | 147 | 37 | 205 | 10 |
| 6/30/2024 | 949 | 150 | 22 | 191 | N/A |
| 3/31/2024 | 916 | 135 | -3 | 175 | N/A |
| 12/31/2023 | 906 | 158 | 37 | 220 | N/A |
| 9/30/2023 | 899 | 152 | 6 | 182 | N/A |
| 6/30/2023 | 873 | 143 | 72 | 217 | N/A |
| 9/30/2022 | 821 | 125 | 29 | 182 | N/A |
| 9/30/2021 | 649 | 101 | 34 | 132 | N/A |
| 9/30/2020 | 584 | 77 | 19 | 104 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: 1SXP's forecast earnings growth (15.8% per year) is above the savings rate (1.4%).
Earnings vs Market: 1SXP's earnings (15.8% per year) are forecast to grow faster than the Austrian market (8.7% per year).
High Growth Earnings: 1SXP's earnings are forecast to grow, but not significantly.
Revenue vs Market: 1SXP's revenue (10.7% per year) is forecast to grow faster than the Austrian market (0.8% per year).
High Growth Revenue: 1SXP's revenue (10.7% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: 1SXP's Return on Equity is forecast to be low in 3 years time (18.9%).